Science to advance liver health
Nonalcoholic Fatty Liver Disease (NAFLD) is a worldwide problem affecting 25% to 35% of the total population. Patients with steatosis that also have other metabolic comorbidities have an increased risk of accelerated disease progression as well as a higher mortality. Early diagnosis and treatment are crucial to help slow or even reverse disease progression.
The forum provides you with the tools necessary to provide the best care for your patients.
Seeing the latest research, hearing clinical insights and having an opportunity to discuss with leading experts is an important way for you, the practitioner, to enhance your knowledge of NAFLD.
2 SESSIONS
Of conferences and
discussions
8 SPEAKERS
Internationally renowned
experts
6 COUNTRIES
Around the virtual table
6 reasons to participate
 |
Enhance your knowledges about the burden of Nonalcoholic Fatty Liver Disease (NAFLD) and the importance to treat it to improve patients' lives. |
 |
Discuss new trends regarding liver disease and their management. |
 |
Empower yourself to tackle the most important challenges of early diagnosis and treatment. |
 |
Evaluate patient cases covering the most prevalent patient profiles. |
 |
Discover an exciting resource of educational and patient materials. |
 |
Expand your network and initiate collaborations. |